LAG3 and neoplasm: The tribodies containing the anti-PD-1 or anti-LAG-3 scFv (53D and 53G) showed up to the 60–70% of tumor cells lysis and those with the anti-PD-L1 scFv (53L1 and 53L10) led to 80–90% of tumor cell lysis.